Trial Pharma Kft

Budapest 1023

1 studies enrolling now · 1 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Obesity, Overweight

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now